Axxcess Wealth Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-5,117
Closed -$203K 939
2024
Q4
$203K Sell
5,117
-2,613
-34% -$98.9K ﹤0.01% 817
2024
Q3
$263K Buy
+7,730
New +$217K 0.01% 735
2022
Q2
Sell
-8,532
Closed -$235K 674
2022
Q1
$235K Buy
8,532
+54
+0.6% +$1.54K 0.02% 540
2021
Q4
$349K Buy
+8,478
New +$375K 0.03% 444

Other funds holding VCYT

Axxcess Wealth Management's VCYT Position: Q1 2025 in Review

Axxcess Wealth Management sold out of Veracyte (VCYT) in Q1 2025, closing a stake of 5,117 shares — an estimated $203K sold.

Axxcess Wealth Management first reported a position in VCYT in Q4 2021 and held it in 4 quarters. The position peaked at $349K in Q4 2021. 287 funds tracked by Wall St. Rank hold VCYT as of Q1 2025.

  • Axxcess Wealth Management reported no remaining Veracyte position as of Q1 2025 after selling out during the quarter.
  • Axxcess Wealth Management sold 5,117 Veracyte shares in Q1 2025, an estimated $203K.
  • Axxcess Wealth Management first reported a position in Veracyte in Q4 2021 and held it in 4 quarters.
  • Axxcess Wealth Management's Veracyte position peaked at $349K in Q4 2021.
  • 287 funds tracked by Wall St. Rank held Veracyte as of Q1 2025.

Based on Axxcess Wealth Management's 13F filing for Q1 2025, filed 30 Apr 2025.